Virginia Merino

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Pharmaceutics

Molecular pharmaceutics

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Universitat de Valencia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat de Valencia Nov 09 2017

Spain

Catedrática Universidad :: Farmacia y Tecnología Farmacéutica

Universitat de València Aug 19 1999 - Nov 08 2017

Spain

Titular Universidad :: Farmacia y Tecnología Farmacéutica

Universitat de València May 01 1995 - Sep 18 1995

Spain

Ayudante LRU :: Farmacia y Tecnología Farmacéutica

Universitat de València Facultat de Farmacia Jan 01 1995 - Apr 30 1995

Spain

Profesor asociado :: Farmacia y Tecnología Farmacéutica

Publications

Isabel González-Álvarez, Alejandro Ruiz-Picazo, Ruben Selles-Talavera, Andres Figueroa-Campos, Virginia Merino, Marival Bermejo, Marta González-Álvarez
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug. Pharmaceutics 16 (3) (2024)
Isabel González-Álvarez, Alejandro Ruiz-Picazo, Ruben Selles-Talavera, Andres Figueroa-Campos, Virginia Merino, Marival Bermejo, Marta González-Álvarez
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug. Pharmaceutics 16 (3) (2024)
Andreu Mañez-Asensi, Mª Jesús Hernández, Victor Mangas Sanjuan, Ana Salvador, Matilde Merino-Sanjuán, Virginia Merino
Impact of Time on Parameters for Assessing the Microstructure Equivalence of Topical Products: Diclofenac 1% Emulsion as a Case Study. Pharmaceutics 16 (6) (2024)
Gema J Cabañero-Resta, Bárbara Sánchez-Dengra, Alejandro Ruiz-Picazo, Marival Bermejo, Virginia Merino, Isabel González-Álvarez, Marta González-Álvarez
Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole. Pharmaceutics 16 (5) (2024)
Gema J Cabañero-Resta, Bárbara Sánchez-Dengra, Alejandro Ruiz-Picazo, Marival Bermejo, Virginia Merino, Isabel González-Álvarez, Marta González-Álvarez
Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole. Pharmaceutics 16 (5) (2024)
Andreu Mañez-Asensi, Mª Jesús Hernández, Victor Mangas Sanjuan, Ana Salvador, Matilde Merino-Sanjuán, Virginia Merino
Impact of Time on Parameters for Assessing the Microstructure Equivalence of Topical Products: Diclofenac 1% Emulsion as a Case Study. Pharmaceutics 16 (6) (2024)
Isabel González-Álvarez, Alejandro Ruiz-Picazo, Ruben Selles-Talavera, Andres Figueroa-Campos, Virginia Merino, Marival Bermejo, Marta González-Álvarez
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug. Pharmaceutics 16 (3) (2024)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Carlos Bueno-López, Carlos Tamarit-Martínez, Adrián M Alambiaga-Caravaca, Cristina Balaguer-Fernández, Virginia Merino, Alicia López-Castellano, Vicent Rodilla
3D Printing of Temporary Prostheses for Controlled-Release of Drugs: Design, Physical Characterization and Preliminary Studies. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Adrian H Teruel, Isabel González-Álvarez, Marival Bermejo, Virginia Merino, Maria Dolores Marcos, Felix Sancenon, Marta Gonzalez-Alvarez, Ramón Martínez-Máñez
New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy. International journal of molecular sciences 21 (18) (2020)
Zhengguo Xu, Victor Mangas Sanjuan, Matilde Merino-Sanjuán, Virginia Merino, Alfredo Garcia-Arieta
Influence of Inter- and Intra-Batch Variability on the Sample Size Required for Demonstration of Equivalent Microstructure of Semisolid Dosage Forms. Pharmaceutics 12 (12) (2020)
Mayank Singhal, Virginia Merino, Michela Rosini, Andrea Cavalli, Yogeshvar N Kalia
Controlled Iontophoretic Delivery in Vitro and in Vivo of ARN14140-A Multitarget Compound for Alzheimer's Disease. Molecular pharmaceutics 16 (8) (2019)
Adrián H Teruel, Édgar Pérez-Esteve, Isabel González-Álvarez, Marta González-Álvarez, Ana M Costero, Daniel Ferri, Pablo Gaviña, Virginia Merino, Ramón Martínez-Máñez, Félix Sancenón
Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease. Molecular pharmaceutics 16 (6) (2019)

Virginia Merino.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Virginia Merino